Nordic Issuing

Ongoing case

Phase Holographics Imaging PHI AB

Back to all cases

Phase Holographics Imaging PHI AB

30 Mar - 13 Apr 2022Rights issue

After successful collaboration between the Competence Center for Circuit Design (CCCD) at Lund University and PHI’s founders resulting in M1, the first prototype of the HoloMonitor product line, PHI was founded in 2004.

PHI’s time-lapse cytometers are designed to non-invasively explore the kinetics of cellular responses, rather than just providing snapshots the way traditional endpoint assays do. PHI’s time-lapse cytometers are based on a novel technology – holographic microscopy – that automatically analyzes living cells in ways not previously possible.

Read more on the company's website

The offer in summary

Record date: 24 March 2022

Subscription period: 30 March 2022 - 13 April 2022

Terms: One (1) previously owned share gives one (1) unit right. Seventeen (17) unit rights entitles the holder to subscribe for one (1) unit. Each unit consists of nine (9) newly issued shares, five (5) warrants of series TO 3, and two (2) warrants of series TO 4. The warrants are free of payment.

Subscription price: 85.50 SEK per unit

The offer: Rights issue of maximum 846 763 units, which corresponds to ca 72 MSEK.

Trading with unit rights: Until 8 April 2022

Marketplace: Spotlight Stock Market

Financial advisor: Sedermera Corporate Finance


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.